At first glance, a gut hormone that regulates blood sugar and a primary male sex hormone don’t seem to have much to do with each other. But the connection between GLP-1 and testosterone is real — mediated through insulin resistance, visceral fat, and the hypothalamic signaling that controls testosterone production. Men with low testosterone are more likely to have impaired GLP-1 responses. Men with poor GLP-1 activity are more likely to develop the metabolic conditions that suppress testosterone. Understanding this bidirectional relationship matters for any man trying to support hormonal health naturally — and the evidence is more substantial than most conversations about testosterone acknowledge.
How Testosterone Is Regulated — and Where the System Breaks Down
Testosterone production follows a chain of command. The hypothalamus releases GnRH (gonadotropin-releasing hormone), which signals the pituitary gland to release LH (luteinizing hormone). LH travels to the testes and signals Leydig cells to produce testosterone. This axis — hypothalamus to pituitary to testes — is sensitive to metabolic signals, not just reproductive ones.
Insulin resistance disrupts this axis at the hypothalamic level. High circulating insulin sends signals to the hypothalamus that reduce GnRH pulsatility, which cascades down to lower LH output and reduced testicular testosterone production. This is why men with type 2 diabetes and metabolic syndrome consistently have lower testosterone levels than metabolically healthy men of the same age — the metabolic disruption directly suppresses the hormonal axis.
Visceral fat compounds this problem by converting testosterone to estrogen via the aromatase enzyme. The more visceral fat a man carries, the more testosterone gets aromatized, and the lower his net testosterone levels. As testosterone falls, muscle mass declines and fat storage increases — particularly viscerally — completing a feedback loop that becomes harder to break the longer it runs.
Where GLP-1 Enters the Picture
GLP-1 — glucagon-like peptide-1 — is released from gut L-cells after eating to moderate post-meal insulin output, slow digestion, and signal satiety. Its most direct relationship with testosterone is through insulin sensitivity. By reducing the magnitude of post-meal insulin spikes and improving how cells respond to insulin over time, GLP-1 activity reduces the hyperinsulinemia that suppresses the hypothalamic-pituitary-testicular axis.
There’s also evidence that GLP-1 receptors exist in the testes and pituitary gland, suggesting GLP-1 may have more direct effects on testosterone production beyond just insulin modulation. A 2021 study found GLP-1 receptors expressed in human Leydig cells — the testosterone-producing cells in the testes. Animal studies have shown GLP-1 receptor activation can directly stimulate testosterone output in Leydig cells independent of LH. This is early and preliminary data, but it opens the possibility that GLP-1’s relationship with testosterone is more direct than simply working through insulin.
What the Prescription Drug Evidence Shows
The clearest human evidence comes from trials of prescription GLP-1 receptor agonists in obese men. Several studies using semaglutide and liraglutide in men with obesity and low testosterone have found significant improvements in total testosterone alongside visceral fat reduction and insulin sensitivity gains. A 2023 analysis found that obese men treated with semaglutide saw testosterone rise by an average of 2–3 nmol/L — a clinically meaningful increase that correlated with visceral fat loss rather than overall weight loss.
The key observation from these trials is that testosterone improvements track with visceral fat reduction and insulin sensitivity improvement more closely than with total weight loss. This suggests the mechanism is metabolic — better insulin signaling restoring hypothalamic function and reduced aromatization from less visceral fat — rather than purely a calorie deficit effect.
Natural GLP-1 boosters won’t replicate these drug effects, but they work through the same underlying mechanisms. The question is whether the more modest improvements in insulin sensitivity achievable naturally are enough to produce detectable improvements in testosterone — and the answer, for men with significant metabolic dysfunction as a driver of low testosterone, is likely yes.
Low Testosterone and Impaired GLP-1: A Two-Way Problem
The relationship runs in both directions. Low testosterone independently worsens insulin resistance and promotes visceral fat accumulation — the same conditions that blunt GLP-1 activity. This creates a feedback loop where low GLP-1 worsens insulin resistance, which suppresses testosterone, which further worsens insulin resistance and visceral fat, which further weakens GLP-1 responses.
Several studies have shown that men with hypogonadism (clinically low testosterone) have significantly blunted incretin responses after meals — meaning lower and slower GLP-1 release compared to testosterone-sufficient men of the same metabolic profile. Whether restoring testosterone directly improves GLP-1 responses has been less studied, but testosterone replacement therapy in hypogonadal men does improve insulin sensitivity and reduce visceral fat — which would indirectly support better GLP-1 function.
For men with both low testosterone and metabolic dysfunction, addressing the metabolic side — insulin resistance, visceral fat, GLP-1 impairment — is a necessary part of the hormonal recovery picture, not a separate concern.
Natural GLP-1 Support as a Testosterone-Friendly Strategy
No natural GLP-1 booster directly raises testosterone. What they can do is address the metabolic conditions that suppress it — particularly insulin resistance and visceral fat accumulation. For men whose low testosterone is primarily driven by metabolic dysfunction rather than primary testicular failure, this indirect approach can produce real hormonal improvements.
Berberine
Berberine is the natural supplement with the most relevant evidence. It activates AMPK, improving cellular insulin sensitivity — directly reducing the hyperinsulinemia that suppresses hypothalamic GnRH pulsatility. It also appears to stimulate GLP-1 secretion from gut cells, adding another pathway toward better post-meal blood sugar regulation.
In men with metabolic syndrome — a condition strongly associated with low testosterone — berberine’s improvements in fasting insulin, blood sugar, and waist circumference address the primary metabolic drivers of testosterone suppression. There are no large trials specifically measuring testosterone as a primary outcome in men taking berberine, but the mechanistic case is sound and the metabolic trial data is strong. Standard dose: 500 mg three times daily with meals.
Resistance Training
Resistance training is the lifestyle intervention with the most direct evidence for both improving testosterone and reducing visceral fat. It stimulates acute testosterone release, builds muscle mass that improves glucose clearance, activates AMPK in muscle cells, and reduces visceral fat over time — all in directions that support the GLP-1-insulin-testosterone axis. Three to four sessions per week of progressive resistance exercise produces consistent improvements in both metabolic markers and testosterone levels in men with obesity and insulin resistance.
Dietary Protein and Fat
Testosterone synthesis requires adequate dietary fat — particularly saturated and monounsaturated fats, which serve as precursors for steroid hormone production. Very low-fat diets are consistently associated with lower testosterone in men. At the same time, protein at each meal provides the strongest dietary GLP-1 stimulus, stabilizing blood sugar and reducing post-meal insulin spikes. The dietary pattern that best supports both GLP-1 and testosterone is one that includes adequate fat from whole food sources (eggs, meat, dairy, olive oil, nuts) and prioritizes protein at every meal.
Refined carbohydrates and ultra-processed foods work against this goal on both fronts — they produce large insulin spikes that blunt GLP-1 effectiveness and contribute to the insulin resistance that suppresses testosterone. Our article on healthy fats and GLP-1 covers the dietary fat picture in detail.
Zinc and Vitamin D
Two micronutrients have direct evidence for supporting testosterone alongside metabolic health. Zinc is a cofactor for testosterone synthesis enzymes and for insulin signaling pathways — deficiency independently lowers both testosterone and insulin sensitivity. Men who sweat heavily (through exercise or heat) are particularly prone to zinc depletion. A dose of 25–45 mg of zinc daily is the range used in testosterone-relevant supplementation studies.
Vitamin D functions as a steroid hormone precursor and has receptors in Leydig cells. Deficiency is associated with lower testosterone in multiple observational studies, and supplementation trials in deficient men show modest testosterone improvements. Maintaining adequate vitamin D (2,000–4,000 IU daily, with levels confirmed by testing) supports both hormonal and metabolic health. These aren’t GLP-1 boosters directly, but they address nutritional gaps that independently affect both testosterone and insulin sensitivity.
Sleep
Testosterone production is highest during deep sleep — approximately 70% of daily testosterone release occurs during sleep. A single week of sleeping five hours per night reduces testosterone levels in healthy young men by 10–15%, according to research from the University of Chicago. Chronic sleep deprivation, which also worsens insulin resistance and impairs GLP-1 regulation, creates a hormonal environment that undermines testosterone production regardless of what else a man is doing for his metabolic health.
Protecting sleep quality — targeting seven to nine hours, maintaining consistent sleep timing, and addressing perimenopausal or stress-related sleep disruption — is one of the highest-leverage hormonal interventions available for men, and it costs nothing.
When Natural Approaches Aren’t Enough
It’s worth being honest about the limits here. For men with primary hypogonadism — where the testes themselves have reduced testosterone-producing capacity due to age, injury, or genetic factors — natural metabolic support will not fully restore testosterone to optimal levels. The metabolic improvements are still valuable, but they’re addressing a secondary driver rather than the primary one.
For men whose low testosterone is primarily driven by metabolic dysfunction — excess visceral fat, insulin resistance, poor sleep, sedentary lifestyle — natural GLP-1 support and the accompanying lifestyle changes can produce meaningful hormonal improvements. The distinction matters for setting realistic expectations and knowing when a conversation with a doctor about testosterone replacement therapy is warranted.
If you’re dealing with symptoms of low testosterone — fatigue, reduced libido, declining muscle mass, mood changes, difficulty with body composition — a total testosterone and free testosterone blood test is the necessary starting point. Testing fasting insulin at the same time gives you the metabolic picture that determines how much of the hormonal deficit is addressable through natural approaches.
Supporting GLP-1 and Testosterone Together: A Practical Summary
The overlap between what supports GLP-1 and what supports testosterone is substantial — because both are downstream of the same metabolic health picture. Reduce visceral fat, improve insulin sensitivity, protect sleep, maintain adequate dietary fat and protein, and train with resistance exercise. These interventions address both simultaneously rather than requiring separate strategies for each.
On the supplement side, berberine at 500 mg three times daily with meals is the most evidence-backed natural option for improving insulin sensitivity in men with metabolic dysfunction. Zinc and vitamin D address nutritional gaps that affect both the GLP-1 pathway and testosterone synthesis directly. For a deeper look at how GLP-1 and visceral fat interact specifically in men, our article on GLP-1 and visceral belly fat in men covers the research in detail.